Description
CJC 1295 with DAC – Long-Acting Growth Hormone-Releasing Hormone Analog
CJC 1295 with DAC (Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH) engineered to stimulate the release of growth hormone (GH) from the pituitary gland. The inclusion of DAC significantly extends its half-life, allowing for prolonged activity and fewer injections compared to non-DAC counterparts.
By binding to albumin, CJC 1295 with DAC resists enzymatic degradation and clearance, enabling a steady and sustained release of growth hormone over several days. This makes it a preferred choice in research focused on growth hormone regulation, body composition, and anti-aging interventions.
Key Features and Benefits:
✅ Extended half-life of up to 8 days for reduced dosing frequency
✅ Promotes sustained increases in growth hormone and IGF-1 levels
✅ Supports research into muscle growth, fat metabolism, and tissue repair
✅ High purity and quality, ideal for research purposes
Mechanism of Action:
CJC 1295 with DAC works by stimulating the pituitary gland to release growth hormone in a pulsatile manner, mimicking the body’s natural secretion patterns. The addition of DAC allows the peptide to bind to serum proteins, reducing renal clearance and enzymatic breakdown, thereby maintaining biological activity for a prolonged period.
Specifications:
- Synonyms: CJC-1295 DAC, Modified GRF (1-29) with DAC
- Molecular Formula: C165H271N47O46
- CAS Number: 863288-34-0
- Appearance: White lyophilized powder
- Storage: refrigerate at 2-8°C


